Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

697 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bronchiectasis: an update on current pharmacotherapy and future perspectives.
Sidhu MK, Mandal P, Hill AT. Sidhu MK, et al. Among authors: mandal p. Expert Opin Pharmacother. 2014 Mar;15(4):505-25. doi: 10.1517/14656566.2014.878330. Epub 2014 Jan 13. Expert Opin Pharmacother. 2014. PMID: 24410485 Review.
A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.
Mandal P, Sidhu MK, Kope L, Pollock W, Stevenson LM, Pentland JL, Turnbull K, Mac Quarrie S, Hill AT. Mandal P, et al. Respir Med. 2012 Dec;106(12):1647-54. doi: 10.1016/j.rmed.2012.08.004. Epub 2012 Sep 1. Respir Med. 2012. PMID: 22947443 Clinical Trial.
Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis.
Mandal P, Morice AH, Chalmers JD, Hill AT. Mandal P, et al. Respir Med. 2013 Jul;107(7):1008-13. doi: 10.1016/j.rmed.2013.04.006. Epub 2013 May 15. Respir Med. 2013. PMID: 23683772
Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.
Mandal P, Sidhu MK, Donaldson LS, Chalmers JD, Smith MP, Turnbull K, Scott J, Hill AT. Mandal P, et al. QJM. 2013 Jan;106(1):27-33. doi: 10.1093/qjmed/hcs173. Epub 2012 Sep 27. QJM. 2013. PMID: 23019590 Clinical Trial.
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.
Choudhury G, Mandal P, Singanayagam A, Akram AR, Chalmers JD, Hill AT. Choudhury G, et al. Among authors: mandal p. Clin Microbiol Infect. 2011 Dec;17(12):1852-8. doi: 10.1111/j.1469-0691.2011.03542.x. Epub 2011 Sep 15. Clin Microbiol Infect. 2011. PMID: 21919994
Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.
Chalmers JD, Singanayagam A, Akram AR, Choudhury G, Mandal P, Hill AT. Chalmers JD, et al. Among authors: mandal p. J Antimicrob Chemother. 2011 Feb;66(2):416-23. doi: 10.1093/jac/dkq426. Epub 2010 Nov 16. J Antimicrob Chemother. 2011. PMID: 21081545
Statins in community acquired pneumonia: Evidence from experimental and clinical studies.
Chalmers JD, Short PM, Mandal P, Akram AR, Hill AT. Chalmers JD, et al. Among authors: mandal p. Respir Med. 2010 Aug;104(8):1081-91. doi: 10.1016/j.rmed.2010.04.005. Epub 2010 May 5. Respir Med. 2010. PMID: 20447815 Review.
Developing drug therapies in bronchiectasis.
Sidhu MK, Mandal P, Hill AT. Sidhu MK, et al. Among authors: mandal p. Expert Opin Investig Drugs. 2015 Feb;24(2):169-81. doi: 10.1517/13543784.2015.971153. Epub 2014 Oct 11. Expert Opin Investig Drugs. 2015. PMID: 25307313 Review.
Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.
Mandal P, Chalmers JD, Graham C, Harley C, Sidhu MK, Doherty C, Govan JW, Sethi T, Davidson DJ, Rossi AG, Hill AT. Mandal P, et al. Lancet Respir Med. 2014 Jun;2(6):455-63. doi: 10.1016/S2213-2600(14)70050-5. Epub 2014 Mar 24. Lancet Respir Med. 2014. PMID: 24717640 Clinical Trial.
Bronchiectasis: breaking the cycle of inflammation and infection.
Mandal P, Hill AT. Mandal P, et al. Lancet Respir Med. 2013 Mar;1(1):e5-6. doi: 10.1016/S2213-2600(13)70005-5. Epub 2013 Jan 14. Lancet Respir Med. 2013. PMID: 24321816 No abstract available.
697 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback